A first: Glaxo will stop paying doctors to pitch drugs

Glaxo paid $3 billion in fines to settle
allegations of fraud regarding this diabetes drug

The depth of the corruption of the pharmaceutical industry is illustrated by the fact that in a first Glaxo Smith Kline announces that it will stop paying doctors to promote drugs and stop paying sales people by the number of prescriptions written. The cynic in me says - wait for the fine print. Take a look at its history of fraud and you will see why I have my doubts.

- GWC

by Katie Thomas - New York Times

The British drug maker GlaxoSmithKline will no longer pay doctors to promote its products and will stop tying compensation of sales representatives to the number of prescriptions doctors write, its chief executive said Monday, effectively ending two common industry practices that critics have long assailed as troublesome conflicts of interest.